drugset / Trial / NCT03271528
Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers
Phase 1
Completed
66 enrolled
Boston Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This is a double-blind, randomized, placebo-controlled, crossover design trial tested the effect of lacosamide on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this study was to determine whether lacosamide, a novel anticonvulsant that is FDA-approved for treating partial seizures, has effects on alcohol craving and consumption.
Timeline
- Start
- 2018-04-15
- Primary completion
- 2020-08-31
- Completion
- 2020-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 300 mg | — |